Shenzhen YHLO Biotech Co., Ltd. (SHA:688575)
China · Delayed Price · Currency is CNY 10.53
+0.23 (2.23%)
Sep 30, 2026, 3:00 PM CST
Shenzhen YHLO Biotech Revenue
Shenzhen YHLO Biotech had revenue of 490.14M CNY in the quarter ending June 30, 2026, with 25.47% growth. This brings the company's revenue in the last twelve months to 1.89B, up 1.62% year-over-year. In the year 2025, Shenzhen YHLO Biotech had annual revenue of 1.81B, down -9.99%.
Revenue (ttm)
1.89B
Revenue Growth
+1.62%
P/S Ratio
3.18
Revenue / Employee
1.12M
Employees
1,689
Market Cap
6.02B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.81B | -200.99M | -9.99% |
| Dec 31, 2024 | 2.01B | -41.48M | -2.02% |
| Dec 31, 2023 | 2.05B | -1.93B | -48.42% |
| Dec 31, 2022 | 3.98B | 2.80B | 237.95% |
| Dec 31, 2021 | 1.18B | 178.89M | 17.91% |
| Jan 1, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Wuhan Huakang Century Clean Technology | 2.47B |
| Edan Instruments | 2.11B |
| INKON Life Technology | 2.06B |
| Guangzhou Wondfo Biotech Co.,Ltd | 1.88B |
| BMC Medical | 1.38B |
| Beijing Wandong Medical Technology | 1.38B |
| Shenzhen Lifotronic Technology | 1.13B |
| Getein Biotech | 1.09B |
Shenzhen YHLO Biotech News
- 5 weeks ago - Shenzhen YHLO Biotech Quarterly report: Q2 2026 - Filings
- 5 months ago - Shenzhen YHLO Biotech Annual report: H2 2025 - Filings
- 5 months ago - Shenzhen YHLO Biotech Quarterly report: Q1 2026 - Filings
- 11 months ago - Shenzhen YHLO Biotech Quarterly report: Q3 2025 - Filings